GSK to pay $2.2 billion to settle 93% of Zantac-related lawsuits. GSK targets £38 billion in sales by 2031, but market estimates fall short at £35.7 billion These cases account for 93% of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback